JW Holdings Corporation (KRX:096760)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,885.00
+60.00 (1.57%)
Nov 4, 2026, 3:30 PM KST

JW Holdings Revenue

JW Holdings had revenue of 266.47B KRW in the quarter ending June 30, 2026, with 16.68% growth. This brings the company's total for the last twelve months to 1.01T, up 10.18% year-over-year. In the year 2025, JW Holdings had annual revenue of 969.57B with 9.22% growth. That makes JW Holdings the 9,022nd largest company in the world by revenue and 410th in South Korea.

Revenue (ttm)
1.01T
Revenue Growth
+10.18%
P/S Ratio
0.26
Revenue / Employee
8.87B
Employees
114
Market Cap
268.81B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Medicines 1.17T 91.5%
  • Holding Company Business 40.86B 3.2%
  • Medical Equipment 35.99B 2.8%
  • Other 30.86B 2.4%

By Geography

Chart
  • Korea 1.24T 97.5%
  • Asia 18.88B 1.5%
  • Other 12.41B 1.0%
  • South America 29.74M 0.0%
Fiscal year ended Dec 31, 2025 See the full JW Holdings breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025969.57B81.86B9.22%
Dec 31, 2024887.71B-40.36B-4.35%
Dec 31, 2023928.07B63.54B7.35%
Dec 31, 2022864.54B75.60B9.58%
Dec 31, 2021788.94B7.42B0.95%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Dong-A ST860.94B
Suheung765.90B
Huons607.75B
Ildong Pharmaceutical582.33B
Samjin Pharmaceuticals274.03B
Whan In Pharm273.47B
HLB Pharmaceutical251.95B
Bukwang Pharmaceutical215.09B
Revenue Rankings